Product Information
Name:BAY 1316957
Brand:Biosynth
Description:BAY 1316957 is a drug that inhibits the enzyme glucuronidation. It is being investigated for the treatment of cancer and neurodegenerative diseases. BAY 1316957 has been shown to inhibit endometriotic lesions in the pelvic cavity, as well as expressed endometriosis. This drug has also been shown to have an anti-nociceptive effect in animal models of cancer. The pharmacokinetic properties of BAY 1316957 have been optimized by altering its receptor subtype.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:441.5 g/mol
Formula:C27H27N3O3
Purity:Min. 95%
Technical inquiry about: BAY 1316957
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.